midodrine and abt 866

midodrine has been researched along with abt 866 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altenbach, RJ; Brioni, JD; Brune, ME; Buckner, SA; Cain, JC; Daza, AV; Gauvin, DM; Holladay, MW; Khilevich, A; Meyer, MD; Milicic, I; Nakane, M; O'Neill, AB; Sullivan, JP; Williams, M	1

Other Studies

1 other study(ies) available for midodrine and abt 866

Article	Year
N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine. Journal of medicinal chemistry, 2002, Sep-26, Volume: 45, Issue:20 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Dogs; Female; Imidazoles; In Vitro Techniques; Ligands; Midodrine; Phenylpropanolamine; Rabbits; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Spleen; Structure-Activity Relationship; Sulfonamides; Urethra	2002

Article

Year

N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine.

Journal of medicinal chemistry, 2002, Sep-26, Volume: 45, Issue:20

Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Dogs; Female; Imidazoles; In Vitro Techniques; Ligands; Midodrine; Phenylpropanolamine; Rabbits; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Spleen; Structure-Activity Relationship; Sulfonamides; Urethra

2002